EcoDrugPlus

Prostaglandin F Receptor

Ensembl ID : ENSSTUG00000039761
Gene Symbol: PTGFR
3 Cross references
195 Possible Orthologues:

Prostaglandin G/h Synthase 2-Like

Ensembl ID : ENSSTUG00000001191
Gene Symbol: LOC115192190
3 Cross references
203 Possible Orthologues:

Prostaglandin G/h Synthase 2-Like

Ensembl ID : ENSSTUG00000026620
Gene Symbol: LOC115156784
3 Cross references
156 Possible Orthologues:

Prostaglandin G/h Synthase 2-Like

Ensembl ID : ENSSTUG00000042310
Gene Symbol: LOC115169908
3 Cross references
156 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSTUG00000023110
Gene Symbol: PTGIR
3 Cross references
181 Possible Orthologues:

Prostaglandin I2 Receptor

Ensembl ID : ENSSTUG00000009559
Gene Symbol: PTGIR
3 Cross references
181 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSTUG00000009525
Gene Symbol: PTGS1
3 Cross references
206 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 1

Ensembl ID : ENSSTUG00000044379
Gene Symbol: PTGS1
3 Cross references
206 Possible Orthologues:

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSSTUG00000022215
Gene Symbol: PTGS2
3 Cross references
202 Possible Orthologues:

Proteasomal Ubiquitin Receptor Adrm1

Ensembl ID : ENSSTUG00000006654
Gene Symbol: LOC115168719
3 Cross references
193 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSSTUG00000021827
Gene Symbol: PSMA1
3 Cross references
202 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSSTUG00000021654
Gene Symbol: PSMA1
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).